Organon OGN
NYSE OGN
$13.73 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Organon (OGN) FCF Margin (2020 - 2026)

Organon (OGN) posted quarterly FCF Margin of 4.17% for Q2 2026, down 718.0% year-over-year from 0.68% in Q2 2025, and down 67.6% on a QoQ basis from 12.88% in Q1 2026.

Organon (OGN) FCF Margin (2020 - 2026) Analysis & Trends

Organon has reported FCF Margin for 7 years, with the latest figure at 4.17% in Q2 2026.

  • FCF Margin for Q2 2026 came in at 4.17%, down 718.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 9.25% (down 122.0% YoY), and the FY2025 annual result was 8.66%, down 328.0% from the prior year.
  • FCF Margin retreated to 4.17% in Q2 2026, from 12.88% in the prior quarter.
  • Over five years, FCF Margin peaked at 21.04% in Q4 2024 and troughed at 2.74% in Q2 2023.
  • A 5-year average of 9.86% and a median of 9.02% in 2022 frame the typical range for FCF Margin.
  • The widest annual swing landed in 2022, when FCF Margin tumbled 7805 bps; it then surged 2140 bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 13.74% in 2022, then surged by 45 bps to 19.9% in 2023, then advanced by 6 bps to 21.04% in 2024, then tumbled by 70 bps to 6.37% in 2025, then tumbled by 35 bps to 4.17% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 4.17% in Q2 2026, 12.88% in Q1 2026, and 6.37% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 28.82%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 18.33%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn 26.96%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 38.60%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn -12.07%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 34.70%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn 44.00%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 2.01%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 3.90%
10 Organon 3.61 Bn 2.47 Bn 847.00 Mn 4.17%

Historic Data

Download Data
DateValue
Jun 30, 2026 4.17%
Mar 31, 2026 12.88%
Dec 31, 2025 6.37%
Sep 30, 2025 13.61%
Jun 30, 2025 11.36%
Mar 31, 2025 2.84%
Dec 31, 2024 21.04%
Sep 30, 2024 6.26%
Jun 30, 2024 18.67%
Mar 31, 2024 1.85%
Dec 31, 2023 19.90%
Sep 30, 2023 13.56%
Jun 30, 2023 -2.74%
Mar 31, 2023 4.42%
Dec 31, 2022 13.74%
Sep 30, 2022 17.05%
Jun 30, 2022 6.69%
Mar 31, 2022 5.74%
Dec 31, 2021 -0.75%
Sep 30, 2021 20.75%